All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

22

Reset

22 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • MasitinibAB1010Phase 33 trials

    AB Science · Amyotrophic Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS), Alzheimer Disease

  • SPG302TazbentetolPhase 33 trials

    Spinogenix · Alzheimer Disease, Schizophrenia, Amyotrophic Lateral Sclerosis

  • PridopidinePhase 32 trials

    Prilenia · Amyotrophic Lateral Sclerosis, Huntington Disease

  • Shanghai Zhimeng Biopharma, Inc. · ALS (Amyotrophic Lateral Sclerosis), Focal Epilepsy

  • COYA 302Phase 31 trial

    Coya Therapeutics · Amyotrophic Lateral Sclerosis (ALS)

  • ION363Phase 31 trial

    Ionis Pharmaceuticals · Amyotrophic Lateral Sclerosis

  • MN-166ibudilastPhase 31 trial

    MediciNova · Amyotrophic Lateral Sclerosis

  • ALT001Phase 22 trials

    Darwin Origin (Hubei) Biopharmaceutical Co., Ltd. · Ischemic Stroke in the Sequelae Stage, Amyotrophic Lateral Sclerosis (ALS)

  • CNMAu8gold nanocrystalsPhase 22 trials

    Clene Nanomedicine · Amyotrophic Lateral Sclerosis, Multiple Sclerosis

  • Foralumab NasalPhase 22 trials

    Tiziana Life Sciences LTD · ALS (Amyotrophic Lateral Sclerosis), ALS - Amyotrophic Lateral Sclerosis, ALS

  • VHB937Phase 22 trials

    Novartis · Amyotrophic Lateral Sclerosis (ALS), Alzheimer's Disease

  • AMT-162Phase 21 trial

    UniQure Biopharma B.V. · Amyotrophic Lateral Sclerosis

  • AP-101Phase 21 trial

    AL-S Pharma · Amyotrophic Lateral Sclerosis

  • BIIB147Phase 21 trial

    Biogen · Amyotrophic Lateral Sclerosis

  • CORT113176DazucorilantPhase 21 trial

    Corcept Therapeutics · Amyotrophic Lateral Sclerosis

  • FHND1002Phase 21 trial

    Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)

  • LTX-002Phase 21 trial

    Leal Therapeutics, Inc · Amyotrophic Lateral Sclerosis

  • NB-4746Phase 21 trial

    Nura Bio · Amyotrophic Lateral Sclerosis (ALS)

  • NX210cPhase 21 trial

    Axoltis Pharma · Amyotrophic Lateral Sclerosis

  • PLL001Phase 21 trial

    PLL TX AUSTRALIA PTY LTD · Amyotrophic Lateral Sclerosis, ALS

  • SNUG01Phase 21 trial

    SineuGene Therapeutics Co., Ltd. · Amyotrophic Lateral Sclerosis (ALS)

  • TRCN-1023Phase 21 trial

    Trace Neuroscience, Inc. · Amyotrophic Lateral Sclerosis

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.